Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Schools are not islands: Balancing COVID-19 risk and educational benefits using structural and temporal countermeasures

Jamie A. Cohen, View ORCID ProfileDina Mistry, View ORCID ProfileCliff C. Kerr, Daniel J. Klein
doi: https://doi.org/10.1101/2020.09.08.20190942
Jamie A. Cohen
Institute for Disease Modeling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jcohen@idmod.org
Dina Mistry
Institute for Disease Modeling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dina Mistry
  • For correspondence: dmistry@idmod.org
Cliff C. Kerr
Institute for Disease Modeling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cliff C. Kerr
  • For correspondence: ckerr@idmod.org
Daniel J. Klein
Institute for Disease Modeling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dklein@idmod.org
  • Abstract
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background: School closures around the world contributed to reducing the transmission of COVID-19. In the face of significant uncertainty around the epidemic impact of in-person schooling, policymakers, parents, and teachers are weighing the risks and benefits of returning to in-person education. In this context, we examined the impact of different school reopening scenarios on transmission within and outside of schools and on the share of school days that would need to be spent learning at a distance. Methods: We used an agent-based mathematical model of COVID-19 transmission and interventions to quantify the impact of school reopening on disease transmission and the extent to which school-based interventions could mitigate epidemic spread within and outside schools. We compared seven school reopening strategies that vary the degree of countermeasures within schools to mitigate COVID-19 transmission, including the use of face masks, physical distancing, classroom cohorting, screening, testing, and contact tracing, as well as schedule changes to reduce the number of students in school. We considered three scenarios for the size of the epidemic in the two weeks prior to school reopening: 20, 50, or 110 detected cases per 100,000 individuals and assumed the epidemic was slowly declining with full school closures. For each scenario, we calculated the percentage of schools that would have at least one person arriving at school with an active COVID-19 infection on the first day of school; the percentage of in-person school days that would be lost due to scheduled distance learning, symptomatic screening or quarantine; the cumulative infection rate for students, staff and teachers over the first three months of school; and the effective reproduction number averaged over the first three months of school within the community. Findings: In-person schooling poses significant risks to students, teachers, and staff. On the first day of school, 5-42% of schools would have at least one person arrive at school with active COVID-19, depending on the incidence of COVID in the community and the school type. However, reducing class sizes via A/B school scheduling, combined with an incremental approach that returns elementary schools in person and keeps all other students remote, can mitigate COVID transmission. In the absence of any countermeasures in schools, we expect 6-25% of teaching and non-teaching staff and 4-20% of students to be infected with COVID in the first three months of school, depending upon the case detection rate. Schools can lower this risk to as low as 0.2% for staff and 0.1% for students by returning elementary schools with a hybrid schedule while all other grades continue learning remotely. However, this approach would require 60-85% of all school days to be spent at home. Despite the significant risks to the school population, reopening schools would not significantly increase community-wide transmission, provided sufficient countermeasures are implemented in schools. Interpretation: Without extensive countermeasures, school reopening may lead to an increase in infections and a significant number of re-closures as cases are identified among staff and students. Returning elementary schools only with A/B scheduling is the lowest risk school reopening strategy that includes some in-person learning.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No approvals were required.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The model used is available open source; all data are available from the authors upon request.

https://covasim.org

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 10, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Schools are not islands: Balancing COVID-19 risk and educational benefits using structural and temporal countermeasures
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Schools are not islands: Balancing COVID-19 risk and educational benefits using structural and temporal countermeasures
Jamie A. Cohen, Dina Mistry, Cliff C. Kerr, Daniel J. Klein
medRxiv 2020.09.08.20190942; doi: https://doi.org/10.1101/2020.09.08.20190942
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Schools are not islands: Balancing COVID-19 risk and educational benefits using structural and temporal countermeasures
Jamie A. Cohen, Dina Mistry, Cliff C. Kerr, Daniel J. Klein
medRxiv 2020.09.08.20190942; doi: https://doi.org/10.1101/2020.09.08.20190942

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (48)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4861)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (630)
  • Health Policy (321)
  • Health Systems and Quality Improvement (206)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5343)
  • Intensive Care and Critical Care Medicine (331)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (440)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (781)
  • Public and Global Health (1817)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)